Dose escalation study of GS 9620 in volunteers

Trial Profile

Dose escalation study of GS 9620 in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Feb 2013

At a glance

  • Drugs Vesatolimod (Primary)
  • Indications Hepatitis B; Hepatitis C
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 12 Feb 2013 Results published in Antiviral Therapy.
    • 03 Apr 2011 Results presented at the 46th Annual Meeting of the European Association for the Study of the Liver.
    • 01 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top